Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

Abstract Background Chemotherapy‐induced peripheral neuropathy (CIPN) is a significant and difficult to manage side effect of neurotoxic chemotherapies. Several risk factors for CIPN have been identified to date, but inconsistencies and methodological limitations exist in past research. Also, a limi...

Full description

Bibliographic Details
Main Authors: Alex Molassiotis, Hui Lin Cheng, Kwun To Leung, Yu Chung Li, Kam Hung Wong, Joseph Siu Kie Au, Raghav Sundar, Alexandre Chan, Terrence Rong De Ng, Lorna K. P. Suen, Choi Wan Chan, Janelle Yorke, Violeta Lopez
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Brain and Behavior
Subjects:
cancer
chemotherapy‐induced peripheral neuropathy
platinum chemotherapy
risk factors
taxanes
Online Access:https://doi.org/10.1002/brb3.1312

Internet

https://doi.org/10.1002/brb3.1312

Similar Items